St. Jude/PIDS Pediatric Infectious Diseases Research Conference

Hamid Bassiri, MD, PhD
Attending Physician, Divisipon of Infectious Diseases
Children's Hospital of Philadelphia
Chair, St. Jude/PIDS Symposium Transplant Planning Committee

Gabriela Maron, MD, MSc
Medical Director of Clinical Operations
Department of Infectious Diseases
St. Jude Children’s Research Hospital

St. Jude Grand Rounds

The Role of the Intestinal Microbiome in Cancer Immunotherapy

Marcel van den Brink, MD, PhD
President and Chief Physician Executive
City of Hope Los Angeles and National Medical Center

Moderator: Gabriela Maron, MD, MSc

Oral Abstracts Session 2
Abstract Presentation 4: Transplant/ICH

Implementation and Clinical Impact of an Immunocompromised Infectious Diseases Service at a Large Academic Pediatric Hospital

Alexander Plattner, MD, MBA
Washington University School of Medicine

Moderator: Gwenn Skar MD, PhD

Oral Abstracts Session 2
Abstract Presentation 5: General Research

Comparison of Geographic Variation of CMV Glycoprotein B Between Minnesotan and Ugandan Populations

Autumn Kittilson, BS
University of Minnesota Medical School

Moderator: Gwenn Skar MD, PhD

Frontiers in Pediatric Infectious Diseases

Quest for a Chlamydia T cell Vaccine

Toni Darville, MD
Distinguished Professor of Pediatrics and Microbiology & Immunology
Chief, Division of Infectious Diseases
North Carolina Children's Hospital
University of North Carolina at Chapel Hill

Moderator: Matthew Kelly, MD, MPH

Pediatric Transplant/Immunocompromised Hosts Platform

Influenza Vaccine Optimization Strategies in Immunocompromised Hosts

Natasha Halasa MD, MPH
Craig Weaver Professor in Pediactric Infectious Diseases
Vanderbilt University Medical Center

Moderator: Tanvi S. Sharma, MD, MPH

Interactive Session: When Less is More: Risk Stratified Antibiotic Use Practices in Patients with Underlying Malignancies

QA Session

Adam Esbenshade, MD, MSCI
Gabrielle Haeusler, MBBS, FRACP, PhD
Maria Elena Santolaya, MD

Moderator: Gabriela Maron, MD, MSc

When Less is More: Risk Stratified Antibiotic Use Practices in Patients with Underlying Malignancies

Challenging Dogma: Empiric Antibiotic Utilization in Pediatric Oncology with Non-neutropenic Fever

Adam Esbenshade, MD, MSCI
John N. Lukens, Jr. Chair in Pediatric Hematology and Oncology
Vanderbilt University Medical Center

Moderator: Gabriela Maron, MD, MSc

When Less is More: Risk Stratified Antibiotic Use Practices in Patients with Underlying Malignancies

Risk Prediction Models in Children with Fever and Neutropenia

Maria Elena Santolaya, MD
Department of Paediatrics, Hospital Dr Luis Calvo Mackenna
Faculty of Medicine, Universidad de Chile, Santiago, Chile

Moderator: Gabriela Maron, MD, MSc

When Less is More: Risk Stratified Antibiotic Use Practices in Patients with Underlying Malignancies

Less is More . . . When to start and when to stop antibiotics in FN

Gabrielle Haeusler, MBBS, FRACP, PhD
Acting Director, Department of Infectious Diseases
Royal Children's Hospital, Melbourne, Australia

Moderator: Gabriela Maron, MD, MSc

Pediatric Transplant/Immunocompromised Hosts Platform

Virus specific T cells for the treatment of infections following solid organ transplantation.

Thomas M. Pfeiffer, MD
Assistant Professor of Pediatrics
Division of Bone Marrow Transplantation and Cellular Therapy
Washington University School of Medicine in St. Louis

Moderator: Hamid Bassiri, MD PhD

Frontiers in Pediatric Infectious Diseases

Bone Appétit: Host-pathogen interactions during osteomyelitis

Jim Cassat, MD, PhD
Associate Professor of Pediatrics and Pathology, Microbiology, & Immunology
Associate Director, Vanderbilt Institute for Infection, Immunology, and Inflammation
Vanderbilt University Medical Center

Moderator: Gwenn Skar MD, PhD

Wiliam J. Steinbach, MD
Pediatrician in Chief
Arkansas Children's
President, Pediatric Infectious Diseaes Society

Octavio Ramilo, MD
Chair, Department of Infectious Diseases
St. Jude Children’s Research Hospital

Frontiers in Pediatric Infectious Diseases

Bacteriophages: A New Era for Antibacterial Therapy with Ancient Predators

John Bradley, MD
Director, Infectious Diseases
Rady Children's Hospital San Diego

Moderator: Octavio Ramilo, MD

Oral Abstracts Session 3
Abstract Presentation 6: Global Health

Parental Knowledge, Attitudes, and Practices on Pediatric Vaccination in Honduras: Insights and Challenges for Improving Immunization Coverage

Maria Jose Reyes Caceres, MD
UNITEC

Moderator: Hamid Bassiri, MD PhD

Oral Abstracts Session 3
Abstract Presentation 7: Conference Top Abstract

Short Course Compared to Standard Antibiotic Courses for Treatment of Uncomplicated Gram-negative Bacteremia in Pediatric HCT Recipients

Adam Lee, MD
Fellow, University of California, Irvine

Moderator: Monica I. Ardura, DO, MSCS

Randal De Souza, MD
Fellow, Nationwide Children's Hospital

Moderator: Monica I. Ardura, DO, MSCS

Daniel Whitehurst, MD
Clinical Fellow, Cincinnati Children's Hospital Medical Center

Moderator: Monica I. Ardura, DO, MSCS

F. Heath Damron, PhD
Director, Vaccine Development Center
West Virginia University Health Sciences

Moderator: Matthew Kelly, MD, MPH

Alpana Waghmare, MD
Associate Professor, Department of Pediatrics
Division of Infectious Diseases
University of Washington/Seattle Children's Hospital

Moderator: Matthew Kelly, MD, MPH

Gail Rodgers, MD
Deputy Director, Pneumonia
Gates Foundation

Moderator: Matthew Kelly, MD, MPH

2025 John H. Erskine Lecture in Infectious Diseases

RSV Vaccine Development: A New Era of Biologics

Barney Graham, MD, PhD
Director, David Satcher Global Health Equity Institute
Morehouse School of Medicine

Moderator: Octavio Ramilo, MD

Liliana Sánchez-González MD, MPH, CTropMed®
Medical Epidemiologist - Dengue Branch
Centers for Disease Control and Prevention

Pediatric Transplant/Immunocompromised Hosts Platform Presentation 1

A Renaissance of Novel Antifungal Agents: Learning from Expanded Use in Pediatric Patients

Brian T. Fisher, DO, MSCE, MPH
Associate Professor of Pediatrics and Epidemiology
Perelman School of Medicine at the University of Pennsylvania Children’s Hospital of Philadelphia

Moderator: Inci Yildirim, MD, PhD, MSc

Liset C. Olarte, MD, MSCI: Clinical Research and Diversity & Health Equity
Associate Professor of Pediatrics Division of Infectious Diseases
Baylor College of Medicine

Thomas G. Boyce, MD, MPH: Navigating the Challenges of a Smaller ID Practice
Pediatric Infectious Diseases and Immunology
Marshfield Clinic Health System

Emma Mohr, MD, PhD: Physician Scientist
Assistant Professor, Division of Infectious Diseases
University of Wisconsin School of Medicine and Public Health

Neil Surana, MD, PhD
Assistant Professor, Department of Pediatrics Duke University

John Williams, MD
Chief, Pediatric Infectious Diseases University of Pittsburgh School of Medicine UPMC Children’s Hospital of Pittsburgh

Career Development Presentation

How to Develop and Evolve as a [Digital] Medical Educator

Sara Dong, MD
Assistant Professor of Medicine, Division of Infectious Diseases Emory University School of Medicine

Moderator: Emma Mohr, MD, PhD

Sara Dong, MD
Assistant Professor of Medicine, Division of Infectious Diseases Emory University School of Medicine

Moderator: Emma Mohr, MD, PhD

Career Presentation

Remembering 1989. How a Family in India Affected by HIV Shaped my Career

Rana Chakraborty, MD, MSc, FAAP, FRCPCH, D.Phil. (Oxon), FPIDS, FIDSA
Professor and Consultant
Department of Pediatrics and Adolescent Medicine Mayo Clinic College of Medicine and Science

Moderator: Emma Mohr, MD, PhD

Ashish Kumar, MD, PhD
Professor of Pediatrics
Co-director, Histiocytosis Center Cincinnati Children's

Moderator: Hamid Bassiri, MD, PhD

Pediatric Transplant/Immunocompromised Hosts Platform Presentation 2

What's New and on the Horizon for Pneumococcal and RSV Vaccines in Children

Rick Malley, MD
Senior Physician in Medicine, Division of Infectious Diseases Boston Children’s Hospital
Professor of Pediatrics Harvard School of Medicine

Moderator: Inci Yildirim, MD, PhD, MSc

Panel

The Good, Bad & Ugly of Therapeutic Drug Monitoring in Immunocompromised Children

Kevin J. Downes, MD
Assistant Professor of Pediatrics, Perelman School of Medicine University of Pennsylvania
Attending Physician, Division of Infectious Diseases
Children’s Hospital of Philadelphia

Shane Cross, PharmD, BCPS
Clinical Pharmacy Specialist, Antimicrobial Stewardship Department of Pharmacy and Pharmaceutical Sciences
St. Jude Children’s Research Hospital

Moderator: Gabriela Maron, MD, MSc

Oral Abstracts Session 2

Abstract Presentation 4: Transplant

Varvara Probst, MD (Nationwide Children’s Hospital)
Evaluation of CMV T-cell Mediated Immunity in Children with CMV DNAemia After Allogeneic Hematopoietic Cell Transplantation

Moderator: Jessica Snowden, MD, MS, MHPTT

Oral Abstracts Session 2

Abstract Presentation 5: General Research

Matthew Mayorga (Kansas City University)
Bovine Lactoferrin Impairs in-vitro Growth of Neonatal Sepsis-causing Escherichia Coli Clinical Isolates

Moderator: Jessica Snowden, MD, MS, MHPTT

Oral Abstracts Session 3

Abstract Presentation 6: Global Health

Haya Hayek, MD (Vanderbilt University Medical School)
Long-Term Trends in Antibiotic Use in a Low-Resource Medical Setting: Amman, Jordan  (2010–2023)

Moderator: Elizabeth Schlaudecker, MD, MPH, FPIDS, FAAP

Oral Abstracts Session 3

Abstract Presentation 7: Top Abstract Global Submission

Sumanth Cherukumilli, MD (University of Maryland)
High Mortality Rates and Antimicrobial Resistance in Children with Invasive Bacterial Infections in a Tertiary Care Facility in West Africa

Moderator: Elizabeth Schlaudecker, MD, MPH, FPIDS, FAAP

Interactive Debate

Pediatric Transplant ID Goes Global

Elizabeth A. Moulton, MD, PhD
Assistant Professor, Pediatrics - Infectious Diseases Texas Children’s Hospital/Baylor College of Medicine

Moderator: Monica I. Ardura, DO, MSCS, FAAP, FPIDS

Interactive Debate

Pediatric Transplant ID Goes Global

Tanvi Sharma, MD, MPH
Director of Infectious Diseases Pediatric Transplant Center
Boston Children’s Hospital/Harvard Medical School

Moderator: Monica I. Ardura, DO, MSCS, FAAP, FPIDS

Interactive Debate

Pediatric Transplant ID Goes Global

Paul Sue, MD
Associate Professor, Pediatrics Columbia University

Moderator: Monica I. Ardura, DO, MSCS, FAAP, FPIDS

Panel Discussion

Strengthening Pediatric Infectious Disease for the Next 40 Years

Archana Chatterjie, MD, PhD
Dean, Chicago Medical School
Rosalind Franklin University of Medicine and Science

Sallie Permar, MD, PhD
Chair, Department of Pediactrics Weill Cornell Medicine

Juan C. Salazar, MD, MPH, FAAP
Professor and Chair, Department of Pediatrics University of Connecticut School of Medicine
Executive Vice President of Academic Affairs & Physician-in-Chief

Joseph W. St. Geme, MD
Chairman, Department of Pediatrics Children’s Hospital of Philadelphia

Moderator: Neil Surana MD, PhD

Frontiers in Pediatric Infectious Diseases, Lecture 2

The Journey of Protecting Infants from RSV Through Maternal Immunnization

Flor Munoz-Rivas, MD
Associate Professor of Pediatrics
Division of Infectious Diseases and Molecular Virology and Microbiology Baylor College of Medicine

Moderator: Octavio Ramilo, MD

Frontiers in Pediatric Infectious Diseases, Lecture 3

Malaria Vaccine Development, a Career Path in Peds ID

Matthew B. Laurens, MD, MPH , FAAP, FPIDS
Professor of Pediatrics, Medicine, and Pathology Director, Pediatric Infectious Diseases Fellowship
Director, International Clinical Trials Unit, Malaria Research Program Center for Vaccine Development and Global Health (CVD) University of Maryland School of Medicine

Moderator: Jessica Snowden, MD, MS, MHPTT

Challenging Cases in Immunocompromised Hosts

Case 1:

When it (d)rains, it pours: An usual case of chronic supporative otitis in an immunocompromised host

Eleana Vasileiadi, MD (Children’s Hospital of Philadelphia)

Moderator: Manjiree Karandikar, MD, MBS

Challenging Cases in Immunocompromised Hosts

Case 2:

Fever in a Pediatric Liver Transplant Recipient

Mohamad Shieb, MD (Medstar Georgetown University Hospital)

Moderator: Manjiree Karandikar, MD, MBS

Challenging Cases in Immunocompromised Hosts

Case 3

Spider Bite?

Gina Lee, MD (University of Texas Southwestern)

Moderator: Manjiree Karandikar, MD, MBS

Challenging Cases in Immunocompromised Hosts

Case 4:

Septic Shock: More than Meets the Eye

Morgan Martinez, APRN, CPNP-AC (Texas Children’s Hospital)

Moderator: Manjiree Karandikar, MD, MBS

Frontiers in Pediatric Infectious Diseases, Lecture 4

Antimicrobial Stewardship Through the PK Lens

Andrea Hahn, MD, MS
Attending, Pediatric Infectious Diseases Children’s National

Moderator: Octavio Ramilo, MD

Wilson Milton Were, MBChB
Medical Officer, Child Health Services
Department of Maternal, Newborn, Child and Adolescent Health
World Health Organization, Geneva, Switzerland

Moderator: Jimmy Carlucci, MD, MPH

Jeffrey Starke, MD
Professor, Pediatrics-Infectious Disease
Texas Children’s Hospital/Baylor College of Medicine, Houston, TX

Moderator: Inci Yildirim, MD, PhD, MSc

Emma Mohr (University of Wisconsin)
Nicole Salazar-Austin (Johns Hopkins)

Allison Agwu, MD, ScM
Program Director, Pediatric Adolescent Young Adult HIV/AIDS Program
Medical Director, Accessing Care Early (ACE) Clinic
Johns Hopkins University School of Medicine, Baltimore, MD

Moderator: Liz Schlaudecker, MD, MPH

PIDTRAN Research Update

Live Vaccines in Liver and Kidney Solid Organ Transplant

Lara Danziger-Isakov, MD, MPH
Director, Immunocompromised Host Infectious Disease
Cincinnati Children’s Hospital, Cincinnati, OH

Moderator: Inci Yildirim, MD, PhD, MSc

Interactive Debate

Infectious Risk Factors in Solid Organ Transplant Donors and Recipients

Panel members:
Lara Danziger-Isakov, MD, MPH (Cincinnati Children’s Hospital)
Michael Green, MD, MPH (Children’s Hospital Pittsburgh)
Sruti Nadimpalli, MD (Stanford/Lucille Packard Children’s Hospital)
Benjamin Hanisch, MD (Children’s National Hospital)

Moderator: Hamid Bassiri, MD, PhD

Panel Discussion

Pediatric ID 2040: A Vision

Frontiers in Pediatric Infectious Diseases

Immune Responses to Viral Infections During Early Childhood Development

Genevieve Fouda, MD, PhD
Assistant Dean, Faculty Development
Department of Pediatrics, Weill Cornell School of Medicine, New York, NY

Moderator: Jessica Snowden, MD

Frontiers in Pediatric Infectious Diseases

What We Can Learn from Viral Evolution and Immunology

Michael Worobey, PhD
Louise Foucar Marshall Science Research Professor and Department Head
Department of Ecology and Evolutionary Biology
University of Arizona, Tucson, AZ

Moderator: Jessica Snowden, MD

Frontiers in Pediatric Infectious Diseases

New Approaches to Building Better Pertussis Vaccines

C. Buddy Creech, MD, MPH
President, Pediatric Infectious Diseases Society 
Edie Carell Johnson Chair and Professor of Pediatric Infectious Diseases
Director, Vanderbilt Vaccine Research Program, Nashville, TN
Vanderbilt University Medical Center

Moderator: Elaine Tuomanen, MD

Case 1: Marisa Orbea, MD (Baylor College of Medicine) 
Case 2: Lisa Hiskey, DO (Mayo Clinic) 
Case 3: Osama Ibrahim, MD (Hasbro Children’s Hospital)
Case 4: Sandra Castejon Ramirez, MD (St. Jude Children’s Research Hospital) 
Case 5: Maria Gabriela Segura, MD (UT Health McGovern Medical School) 

Moderators: Sanya Thomas, MD and Janine Dailey-Garnes, MD, MPH, MS

2022 John H. Erskine Lecture in Infectious Diseases

Dissecting the Tug-of-War between Staphylococcus aureus and the Host

Victor Torres, PhD
Director, Anti-Microbial Resistant Pathogens (AMR) Program
NYU Grossman School of Medicine, New York, NY

Moderator: Elaine Tuomanen, MD

• Moderator: Hayley Gans, MD, FAAP, FPIDS, FIDSA – Stanford University Medical Center
• Betsy Herold, MD – Albert Einstein College of Medicine
• Hamid Bassiri, MD, PhD – University of Pennsylvania Perelman School of Medicine; Children’s Hospital of Philadelphia

• Moderator: Tanvi Sharma, MD, MPH, FPIDS – Boston Children’s Hospital
• Katelyn Leake, CPNP – Boston Children’s Hospital
• Elizabeth Marini, CPNP – Boston Children’s Hospital
• Jacquie Toia, DNP – Lurie Children’s Hospital
• Krystal Kohlman, PA-C – Stanford Children’s Hospital
• Kira Kuhn, CPNP – Children’s Hospital of Philadelphia

• Moderator: Inci Yildirim, MD, PhD, MSc – Yale School of Medicine
• Ana M Vaughan-Malloy, MD, MPH – Boston Children’s Hospital, Harvard Medical School
• Benjamin Hanisch, MD – Children’s National Medical Center

• Moderator: Tanvi Sharma, MD, MPH, FPIDS – Boston Children’s Hospital
• Lara Danziger-Isakov, MD, MPH – Cincinnati Children’s Hospital Medical Center
• Janet Englund, MD – Seattle Children’s Hospital

• Moderator: Hayley Gans, MD, FAAP, FPIDS, FIDSA – Stanford University School of Medicine
• Josh Wolf, MD, PhD – St. Jude Children’s Research Hospital
• Rachel Wattier, MD, MHS – University of California, San Francisco
• Ted Morton, PharmD – St. Jude Children’s Research Hospital

Grand Rounds:

Curative Therapies for Sickle Cell Disease

Abstract Presentation

Morbidity and Mortality Associated with Respiratory Syncytial Virus (RSV) Among Pediatric Hematopoietic Cell (HCT) and Solid Organ Transplant (SOT) Recipients: Preliminary Results from a Multi-Site U.S. Study

Platform Presentation

Phage Therapy for MDRO and Mycobacteria in Transplant Candidate and Recipients

Research Update

PIDS/St Jude Transplant ID Research Working Group Updates

Platform Presentation

COVID in Pediatric Immunocompromised Host

Case Conferences

Cases in Immunocompromised Hosts

• Moderators: Bill Muller, MD, PhD – Northwestern University Feinberg School of Medicine, 
  Benjamin Hanisch, MD – Children’s National Hospital
• Small but Mighty
  Nicholas Geagan, MD – Children’s National Hospital
  
• A Red Herring
  Elizabeth Christian, MD – Boston Children’s Hospital
• Don’t Rely on the Gram Stain: Fatal Hyperammonemia Syndrome in Two Immunocompromised Pediatric Patients
  Lauren Kushner, MD – Stanford University Medical Center 
  
• You Give Me Fever
  Hannah Bahakel, MD – Cincinnati Children’s Hospital Medical Center
• Infectious Complications of HSCT Therapeutics
  Brianna Ter Haar, MD – Duke University School of Medicine
  
• An Uncommon Agent Involved in Soft Tissue Infection in a Child with Leukemia
  Michel Mata, MD – Hospital Infantil de Mexico

Abstract

Gut Decontamination, the Microbiome, and the Risk of Bloodstream Infections During Pediatric Allogeneic Hematopoietic Cell Transplantation

Interactive Session

Jeopardy

Platform Presentation

Overview of Transplant Immunology

Sandy Feng, MD PhD, University of California San Francisco

Moderators: Mike Green, MD, MPH – University of Pittsburgh School of Medicine, Natasha Halasa, MD, MPH – Vanderbilt University Medical Center

• Variation in Antibiotic Use and Incidence of Surgical Site Infections in Pediatric Liver Transplant Recipients
  Eimear Kitt, MD, FAAP – Children’s Hospital of Philadelphia
• A Multicenter Study Exploring the Epidemiology and Outcomes of COVID-19 Among Pediatric Hematopoietic Cell Transplant, Cellular Therapy and Solid Organ Transplant Recipients: Preliminary Results from the Pediatric COVID-19 U.S. Registry
  Ronald Dallas, PhD – St. Jude Children’s Research Hospital
  
• Antibiotic Exposure and Risk of Cytomegalovirus Viremia Among Pediatric Hematopoietic Stem Cell Transplant Recipients at a Single Institution
  Sarah Heston, MD – Duke University School of Medicine
  
• A Retrospective Study of Valganciclovir Discontinuation Due to Toxicity or Intolerance in Pediatric Solid Organ Transplant Patients
  Marc Foca, MD – Albert Einstein College of Medicine
  
• Pediatric Febrile Neutropenia with Low Risk of Systemic Infection: When Is It Safe to Stop Antibiotics?
  Muayad Alali, MD – Indiana University
  
• Manual Validation of an Automated Tool to Extract Blood Culture and Susceptibility Data from the Electronic Health Record for Children with Acute Myeloid Leukemia
  William Otto, MD – Children’s Hospital of Philadelphia

Moderator: Buddy Creech, MD – Vanderbilt University Medical Center

• The highly conserved stem-loop II RNA element (s2m) is critical for the lifecycle of astrovirus VA1 but is dispensable for SARS-CoV-2
  Andrew B. Janowski, MD – Washington University School of Medicine
• Rapid, Non-Invasive Detection of Non-H. pylori Helicobacter Infections in Immunocompromised Children Using Microbial Cell-Free DNA Next Generation Sequencing in Plasma
  David Berman, DO – Karius Diagnostics
  
• Elucidating key interactions between macrophages and Coccidioides
  Jane Symington, MD, PhD – University of California San Francisco
  
• An RSV live-attenuated vaccine candidate lacking G protein mucin domains is highly attenuated, immunogenic, and effective in RSV prevention in BALB/c mice
  Maria Perez – Emory University
  
• Does Cytomegalovirus (CMV) Status Impact the Host Response to SARS-CoV-2?
  Stephen Isabell – University of Minnesota Medical School
  
• Resolution of thrombocytopenia during treatment for symptomatic congenital cytomegalovirus disease
  Shelby Walcott – University of Alabama at Birmingham
  
• Nasal microbiota differences in young infants are associated with early childhood irritability
  Rachel Bass – Northwestern University Feinberg School of Medicine

Keynote

Why Did My Patient Die? Answers from the Pneumococcal Surface

Luminary in Pediatric Infectious Diseases

My Journey in Pediatric Infectious Diseases: More Than “a Little Help from my Friends”

• Infection Control: Lynn Ramirez, MD, UCSF
• Education: Kathleen McGann, MD, Duke
• Transplant ID: Monica Ardura, DO, MSCS – Nationwide Children’s Hospital
• Basic Science: Anne Rowley, MD – Lurie Children’s Hospital

What About the Kids? Improving Outcomes for Children Living With or Exposed to HIV and Lessons Along the Way
Grace John-Stewart, MD, PhD

Pediatric pandemics: Case study of global HIV from 1981-2022
Sten H. Vermund, MD, PhD

Moderator: Jimmy Carlucci, MD, MPH

Networking Sessions (first of two videos)

Networking Sessions (second of two videos)

Networking Sessions

• Basic Research: Grace John-Stewart, MD, PhD
• Clinical Research: Matthew Laurens, MD, MPH
• Strategies for Incorporating Education/Capacity Building into a Global Health Career: Troy Moon, MD, MPH
• Infection Prevention and Control: Miguela A. Caniza, MD, MPH

The Future of ID Scholarship in Immunocompromised Populations
Michael Green, MD and Natasha Halasa, MD, MPH

The Role of Antimicrobial Stewardship (ASP) and ASP Pharmacists in Transplant ID|
Joshua Wolf, MBBS

The Roles of Advanced Practice Providers (APP) in Transplant ID
Elizabeth Marini, MSN,CPNP Katelyn Leake, MSN,CPNP
Krystal Kohlman,MMS, PA-C, Jacquie Toia, DNP
Carolyn Michaels, MSN,CPNP and Elizabeth Swift, MSN, CPNP

How to Develop a Career in Transplant ID
Janet Englund, MD and Inci Yildirim, MD, PhD, MSc

Debate

Viral specific T-cell immunity can be used to determine immune competence following transplantation

Moderator
Hayley Gans, MD, Stanford University

Debate Team
Amina Ahmed, MD, Levine Children’s Hospital at Carolinas Medical Center and Inci Yildirim, MD, PhD, Yale University School of Medicine

Pro Debater
Lars Pape, MD, University Hospital of Essen

Con Debater
Hamid Bassiri, MD, PhD, Children’s Hospital of Philadelphia

Platform Presentation

Update on Viral Infections in Transplant Patients

Abstract Presentation

Cytomegalovirus Retinitis Among Pediatric Hematopoietic Stem Cell and Solid Organ Transplantation Recipients — A Contemporary Review

Challenging Cases in Hematopoietic Stem Cell Transplant and Oncology Patients
Gabriela Maron, MD, St. Jude Children’s Research Hospital
Inci Yildirim, MD, PhD, MSc, Yale University School of Medicine

Challenging Cases in Solid Organ Transplant Recipients
Flor Munoz-Rivas, MD, Texas Children’s Hospital
Benjamin Hanisch, MD, Children’s National Medical Center

Challenging Cases in Other Immunocompromised Hosts
William Muller, MD, PhD, Lurie Children’s Hospital of Chicago
Amina Ahmed, MD, Levine Children’s Hospital at Carolinas Medical Center

Clinical Features and Management of Pediatric Patients Presenting with New Onset Acute Leukemia and Concomitant COVID-19
Pratik Atul Patel, MD, Emory University School of Medicine

Rifaximin for Prevention of Bloodstream Infections in Pediatric Allogeneic Hematopoietic Cell Transplantation (HCT)
Mehgan Teherani, MD, Emory University School of Medicine

The Safety and Antibody Kinetics of COVID-19 Convalescent Plasma for the Treatment of Moderate to Severe Cases of SARS-CoV-2 Infection in Pediatric Patients
Alvaro Galvis, MD, Children’s Hospital of Orange County

Respiratory and Intestinal Epithelial Cells Exhibit Differential Susceptibility and Innate Immune Responses to Contemporary EV-D68 Isolates
Megan Freeman, MD, PhD, UPMC Children’s Hospital of Pittsburgh

Disease and Immunoprophylaxis Model of Human Nose Organoids to Study SARS-CoV-2 and RSV Infection
Anubama Rajan, PhD, Baylor College of Medicine

Video #1

Video #2

Video #3

Video #4

Video #5 (Audio only)

Welcome and Announcements

Platform Presentation

Towards an HIV Cure – Immune-based Latency Reversal

Platform Presentation

Enterovirus Acute Flaccid Myelitis

Platform Presentation

Looking for the Bacterial Stem Cell-specialized Bacterial Hideouts for Colonization and Persistence

Platform Presentation

COVID-19 Immunology

2021 John H. Erskine Lecture in Infectious Diseases

Quorum-Sensing Communication; From Viruses to Bacteria to Eukaryotes

Bonnie Bassler, PhD, Princeton University

Introduction: Elaine Tuomanen, MD, St. Jude Children’s Research Hospital

Platform Presentation

Transitioning from Fellow to Attending Physician – What Do You Need to Know

Introduction
Anne Blaschke MD, PhD, University of Utah Health Sciences and Ann Chahroudi, MD, PhD, Emory University School of Medicine

A Career in Antimicrobial Stewardship
Alison Tribble, MD, MSCE, University of Michigan
A Career in Medicine/Pediatrics and Clinical Research
Evan Anderson, MD, Emory University School of Medicine
Pathways in Pediatric Infectious Diseases: Clinical Practice, Research, and Public Health
Kristen Feemster, MD, MPH, Merck & Co., Inc.
A Series of Fortunate Events: My Non-Linear Career in Global Health
Chandy John, MD, MS, Indiana University
Panel Discussion: Drs. Alison Tribble, Evan Anderson, Kristen Feemster, and Chandy John